Late Recurrent Post-Transplant Primary Biliary Cirrhosis in British Columbia

Late recurrent primary biliary cirrhosis (PBC) following orthotopic liver transplant remains a controversial topic. The first documented case of recurrence occurring in 16 patients transpl...

Full description

Saved in:
Bibliographic Details
Main Authors: Eric M Yoshida, R Andrew Singh, Robert K Vartanian, David A Owen, Siegfried R Erb, Charles H Scudamore
Format: Article
Language:English
Published: Wiley 1997-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1997/790906
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850236736221741056
author Eric M Yoshida
R Andrew Singh
Robert K Vartanian
David A Owen
Siegfried R Erb
Charles H Scudamore
author_facet Eric M Yoshida
R Andrew Singh
Robert K Vartanian
David A Owen
Siegfried R Erb
Charles H Scudamore
author_sort Eric M Yoshida
collection DOAJ
description Late recurrent primary biliary cirrhosis (PBC) following orthotopic liver transplant remains a controversial topic. The first documented case of recurrence occurring in 16 patients transplanted for PBC and followed at the authors' institution for longer than one year is presented. A 54-year-old man transplanted for PBC developed a cholestatic pattern of enzyme elevation on post-transplant day (PTD) 1305. Repeat antimitochondrial antibody was strongly positive (1:300 to 1:400). A liver biopsy revealed severe bile duct damage, lymphocytic cholangitis, focal periductal noncaseating granuloma and minimal endotheliitis. Recurrent PBC was diagnosed. At the time of orthotopic liver transplant this patient received induction immunosuppression with OKT3 crossed over to cyclosporine (CsA), azathioprine (AZA) and prednisone. AZA was discontinued early and maintenance CsA tapered to a target trough level of 150 to 200 ng/mL by PTD 365. Prednisone was withdrawn by PTD 664. CsA levels during PTDs 1225 to 1305 (before elevation of hepatobiliary enzymes) were below target at 114 to 166 ng/mL. Of the 16 patients, all but three were maintained on CsA, AZA and prednisone. One was on CsA (trough levels on target) and AZA; the other two, including the patient with recurrent PBC, were on CsA only. The trough CsA level of the patient without recurrent PBC has been within the target range. The authors speculate that the underlying defect in immunoregulation in PBC persists post-transplant and that in the patient without recurrent PBC this defect was unmasked by lowered maintenance immunosuppression - allowing recurrence of PBC in a previously stable liver allograft.
format Article
id doaj-art-1166fb45f1a44a6785f99cdec6058d49
institution OA Journals
issn 0835-7900
language English
publishDate 1997-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-1166fb45f1a44a6785f99cdec6058d492025-08-20T02:01:54ZengWileyCanadian Journal of Gastroenterology0835-79001997-01-0111322923310.1155/1997/790906Late Recurrent Post-Transplant Primary Biliary Cirrhosis in British ColumbiaEric M Yoshida0R Andrew Singh1Robert K Vartanian2David A Owen3Siegfried R Erb4Charles H Scudamore5Departments of Medicine, Anatomic Pathology, and Surgery, University of British Columbia, CanadaDepartments of Medicine, Anatomic Pathology, and Surgery, University of British Columbia, CanadaDepartments of Medicine, Anatomic Pathology, and Surgery, University of British Columbia, CanadaDepartments of Medicine, Anatomic Pathology, and Surgery, University of British Columbia, CanadaBritish Columbia Transplant Society, Vancouver, British Columbia, CanadaDepartments of Medicine, Anatomic Pathology, and Surgery, University of British Columbia, CanadaLate recurrent primary biliary cirrhosis (PBC) following orthotopic liver transplant remains a controversial topic. The first documented case of recurrence occurring in 16 patients transplanted for PBC and followed at the authors' institution for longer than one year is presented. A 54-year-old man transplanted for PBC developed a cholestatic pattern of enzyme elevation on post-transplant day (PTD) 1305. Repeat antimitochondrial antibody was strongly positive (1:300 to 1:400). A liver biopsy revealed severe bile duct damage, lymphocytic cholangitis, focal periductal noncaseating granuloma and minimal endotheliitis. Recurrent PBC was diagnosed. At the time of orthotopic liver transplant this patient received induction immunosuppression with OKT3 crossed over to cyclosporine (CsA), azathioprine (AZA) and prednisone. AZA was discontinued early and maintenance CsA tapered to a target trough level of 150 to 200 ng/mL by PTD 365. Prednisone was withdrawn by PTD 664. CsA levels during PTDs 1225 to 1305 (before elevation of hepatobiliary enzymes) were below target at 114 to 166 ng/mL. Of the 16 patients, all but three were maintained on CsA, AZA and prednisone. One was on CsA (trough levels on target) and AZA; the other two, including the patient with recurrent PBC, were on CsA only. The trough CsA level of the patient without recurrent PBC has been within the target range. The authors speculate that the underlying defect in immunoregulation in PBC persists post-transplant and that in the patient without recurrent PBC this defect was unmasked by lowered maintenance immunosuppression - allowing recurrence of PBC in a previously stable liver allograft.http://dx.doi.org/10.1155/1997/790906
spellingShingle Eric M Yoshida
R Andrew Singh
Robert K Vartanian
David A Owen
Siegfried R Erb
Charles H Scudamore
Late Recurrent Post-Transplant Primary Biliary Cirrhosis in British Columbia
Canadian Journal of Gastroenterology
title Late Recurrent Post-Transplant Primary Biliary Cirrhosis in British Columbia
title_full Late Recurrent Post-Transplant Primary Biliary Cirrhosis in British Columbia
title_fullStr Late Recurrent Post-Transplant Primary Biliary Cirrhosis in British Columbia
title_full_unstemmed Late Recurrent Post-Transplant Primary Biliary Cirrhosis in British Columbia
title_short Late Recurrent Post-Transplant Primary Biliary Cirrhosis in British Columbia
title_sort late recurrent post transplant primary biliary cirrhosis in british columbia
url http://dx.doi.org/10.1155/1997/790906
work_keys_str_mv AT ericmyoshida laterecurrentposttransplantprimarybiliarycirrhosisinbritishcolumbia
AT randrewsingh laterecurrentposttransplantprimarybiliarycirrhosisinbritishcolumbia
AT robertkvartanian laterecurrentposttransplantprimarybiliarycirrhosisinbritishcolumbia
AT davidaowen laterecurrentposttransplantprimarybiliarycirrhosisinbritishcolumbia
AT siegfriedrerb laterecurrentposttransplantprimarybiliarycirrhosisinbritishcolumbia
AT charleshscudamore laterecurrentposttransplantprimarybiliarycirrhosisinbritishcolumbia